Table 2. Response of 10 patients with... | American Society of Hematology

Table 2.

Response of 10 patients with factor X deficiency to HDM/ASCT¹²

Patient no.	Response	Melphalan, mg/m²	Factor X, pre-HDM/ASCT, %	Factor X, post-HDM/ASCT, %
4	CR	140	13	42
5^*	Expired	200	16
6^*	Expired	200	16
7	PR	200	17	15
10	CR	140	29	41
14	NR	140	38	39
15	CR	200	40	104
16^*	Expired	200	41
18	PR	140	47	96
19	CR	200	19	86

Patient no.	Response	Melphalan, mg/m²	Factor X, pre-HDM/ASCT, %	Factor X, post-HDM/ASCT, %
4	CR	140	13	42
5^*	Expired	200	16
6^*	Expired	200	16
7	PR	200	17	15
10	CR	140	29	41
14	NR	140	38	39
15	CR	200	40	104
16^*	Expired	200	41
18	PR	140	47	96
19	CR	200	19	86

Patient 5 expired at day 29 post-HDM/ASCT, patient 6 expired at day 15, and patient 16 at 6 months.